Selection from HEOR Bibliography
| Search criteria | ||||
| Philippines |
||||
| Estimating the burden of illness related to genital warts in the Philippines: a nationally representative cross-sectional study | ||||
| Buenconsejo L1, Kothari-Talwar S2, Yee K3, Kulkarni A2, Lara N4, Roset M4, Giuliano AR5, Garland S6 | ||||
| 1 Makati Medical Center, Makati, Philippines 2 Merck & Co. Inc., Kenilworth, NJ, US 3 Cubist Pharmaceuticals, Lexington, MA, US 4 IQVIA, Barcelona, Spain 5 Center for Infection Research in Cancer (CIRC) at Moffitt Cancer Center, Tampa, FL US 6 Royal Women's Hospital, Melbourne, Australia | ||||
| Infect Agent Cancer. 2019 Oct 7;14:26. |
||||
| , Article | ||||
| , Philippines | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31624494 | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease | 2019 | English | , Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Observational study | |
| Asthma control and its direct healthcare costs: findings using a derived Asthma Control Test (ACT) score in eight Asia-Pacific areas. | ||||
| Lai CKW1 Kuo S-H2 de Guia T3 Lloyd A4, Williams AE5, Spencer MD5 | ||||
| 1 Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong 2 National Taiwan University Hospital, Taipei, Taiwan 3 Philippine Heart Centre, Quezon City, The Philippines 4 Fourth Hurdle Consulting Ltd, London, UK 5 GlaxoSmithKine R&D, Greenford, UK | ||||
| European Respiratory Review 2006; 15:(98): 24-29 |
||||
| , Manuscript in preparation | ||||
| , China, Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Vietnam | ||||
| Condition | Year | Language | Analysis type | |
| , Respiratory disease | 2006 | English | , Cost of illness | |